S&S Healthcare Holding Ltd. (TPEX:4198)
Taiwan · Delayed Price · Currency is TWD 43.00
+1.50 (3.61%)
Jul 30, 2026, 1:24 PM CST
S&S Healthcare Holding Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 178 | 204.21 | 240.25 | 254.52 | 254.44 | 122.35 |
Revenue Growth | -25.07% | -15.00% | -5.61% | 0.03% | 107.95% | 20.71% |
Gross Profit Gross Profit Growth | 61.15 | 67.11 | 75.01 | 35.66 | 38.39 | -7.93 |
Operating Income Operating Income Growth | -50.58 | -46.57 | -67.98 | -92.92 | -110.52 | -103.29 |
Net Income Net Income Growth | -48.66 | -47.3 | -41.28 | 103.61 | -66.89 | -95.39 |
Earnings Per Share EPS Growth | -2.02 | -1.96 | -1.71 | 4.49 | -3.77 | -6.52 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Health Food Business Group Health Food Business Group Growth | 48.64 | 41.78 | 42.75 | 22.23 | - | - |
Medical Equipment Business Group Medical Equipment Business Group Growth | 104.48 | 138.45 | 172.13 | 216.2 | 225.25 | 112.86 |
Other Business Group Other Business Group Growth | 24.88 | 23.98 | 25.37 | 16.1 | 29.19 | 9.49 |
Total Total Growth | 178 | 204.21 | 240.25 | 254.52 | 254.44 | 122.35 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 82.47 | 106.85 | 150.02 | 198.99 | 112.32 | 121.88 |
Total Debt Total Debt Growth | 30.34 | 28.44 | 53.32 | 88.08 | 183.91 | 124.06 |
Net Cash (Debt) Net Cash Growth | 52.13 | 78.4 | 96.7 | 110.91 | -71.58 | -2.18 |
Net Cash Growth | -39.05% | -18.92% | -12.81% | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 2.16 | 3.25 | 4.01 | 4.81 | -4.04 | -0.15 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -24.24 | -26.66 | -41.89 | -68.1 | -72.91 | -70.52 |
Capital Expenditures CapEx Growth | -4.86 | -2.46 | -15.85 | -30.61 | -16.17 | -9.52 |
Free Cash Flow Free Cash Flow Growth | -29.1 | -29.12 | -57.74 | -98.7 | -89.07 | -80.04 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 34.36% | 32.87% | 31.22% | 14.01% | 15.09% | -6.48% |
Operating Margin | -28.41% | -22.80% | -28.30% | -36.51% | -43.44% | -84.42% |
Pretax Margin | -28.59% | -23.73% | -19.28% | 40.41% | -27.66% | -77.97% |
Profit Margin | -27.33% | -23.16% | -17.18% | 40.71% | -26.29% | -77.97% |
FCF Margin | -16.35% | -14.26% | -24.03% | -38.78% | -35.01% | -65.42% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 5.95 | - | - |
PS Ratio | 5.62 | 4.31 | 3.21 | 2.42 | 2.15 | 4.11 |